奥精医疗: 奥精医疗：奥精医疗科技股份有限公司股东减持股份计划公告

Core Viewpoint - BioVeda China RMB Investment Limited plans to reduce its shareholding in Aojing Medical Technology Co., Ltd. due to personal financial arrangements, with a maximum reduction of 1,355,515 shares, representing 1% of the total shares [1] Shareholder Reduction Plan - As of the announcement date, BioVeda holds 7,239,358 shares, accounting for 5.28% of Aojing Medical's total shares [1] - The reduction will occur through centralized bidding and block trading, starting from September 22, 2025, to December 22, 2025 [1] - The reason for the reduction is stated as personal financial arrangements [1] Shareholder Background - BioVeda is identified as a controlling shareholder and holds more than 5% of the shares [1] - In the past 12 months, BioVeda has reduced its holdings by 345,087 shares, representing 0.25% of the total shares, at a price range of 17.00 to 17.19 yuan per share [1] Compliance with Lock-up Commitments - The planned reduction is consistent with previous commitments made by BioVeda regarding the lock-up of shares for 12 months post-IPO [2] - There are no other arrangements or commitments that conflict with the current reduction plan [2]